2023

1. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

   The Lancet Infectious Diseases, Vol. 23, Núm. 7, pp. 856-866

2. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study

   The Lancet Respiratory Medicine, Vol. 11, Núm. 4, pp. 341-353